Bank Of America Corp Verastem, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.39 - $0.71 $7,038 - $12,814	18,048 Added 13.03%	156,555 $65,000
Q4 2022 Feb 10, 2023	SELL	$0.33 - $10.44 $110,583 - $3.5 Million	-335,103 Reduced 70.76%	138,507 $55,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $52,853 - $641,130	57,449 Added 13.8%	473,610 $402,000
Q2 2022 Aug 12, 2022	BUY	$1.02 - $1.83 $174,742 - $313,508	171,316 Added 69.97%	416,161 $482,000
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $507,224 - $1 Million	-478,514 Reduced 66.15%	244,845 $346,000
Q4 2021 Feb 08, 2022	BUY	$2.05 - $3.2 $1.26 Million - $1.97 Million	616,856 Added 579.19%	723,359 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $258,907 - $414,863	101,932 Added 2229.97%	106,503 $329,000
Q2 2021 Sep 13, 2021	BUY	$2.57 - $4.85 $11,747 - $22,169	4,571 New	4,571 $19,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.